Home › Research › Inflammation and the immune system
Adaptive immunity in the neuroinflammation of Alzheimer’s disease
Hanchen Liu, Yun Chen, Jing Zhang, Xiaochun Chen. Chinese Medical Journal, 2025-08-05
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
ABSTRACT: Alzheimer's disease (AD) is the most common cause of dementia and is a growing public health challenge. Neuroinflammation has been proposed as a prominent pathological feature of AD and has traditionally been attributed to the innate immune system. However, emerging evidence highlights the involvement of adaptive immunity, particularly T and B lymphocytes, in the neuroinflammatory processes of AD. It remains unclear how adaptive immune responses, originally intended to protect the body, contribute to chronic inflammation and neuronal dysfunction in AD. Here, we review the roles of adaptive immunity, cellular composition, and niches and their contribution to AD development and progression. Notably, we synthesize the crosstalk between adaptive immunity and the innate immune system of the central nervous system (CNS), which is mainly mediated by glial cells and myeloid cells, and their interrelationships with amyloid-β (Aβ)/Tau pathology. We hypothesized that the alterations observed in innate immunity in AD mirror age-related immune alterations, whereas the dysregulation of adaptive immunity contributes more accurately to disease-specific immune responses. Targeting adaptive immunity in the context of neuroinflammation may provide new insights into potential therapeutic strategies designed to modulate immune responses, thereby facilitating the diagnosis, intervention, and treatment of AD.
What this study adds
Evidence grade: Low
This review discusses evidence that T and B lymphocytes of the adaptive immune system, not just the innate immune system, are involved in the neuroinflammation of Alzheimer's disease. It proposes that targeting adaptive immunity might lead to new treatments, but no such treatment has been tested or proven here.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Liu, H., Chen, Y., Zhang, J., & Chen, X. (2025). Adaptive immunity in the neuroinflammation of Alzheimer’s disease. Chinese Medical Journal. https://doi.org/10.1097/cm9.0000000000003695
Vancouver
Liu H, Chen Y, Zhang J, Chen X. Adaptive immunity in the neuroinflammation of Alzheimer’s disease. Chinese Medical Journal. 2025. doi:10.1097/cm9.0000000000003695. PMID: 40764088.
BibTeX
@article{liu2025-40764088,
author = {Liu, Hanchen and Chen, Yun and Zhang, Jing and Chen, Xiaochun},
title = {{Adaptive immunity in the neuroinflammation of Alzheimer’s disease}},
journal = {Chinese Medical Journal},
year = {2025},
doi = {10.1097/cm9.0000000000003695},
pmid = {40764088},
url = {https://doi.org/10.1097/cm9.0000000000003695}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- It remains unclear how adaptive immune responses, originally intended to protect the body, contribute to chronic inflammation and neuronal dysfunction in AD.
- Here, we review the roles of adaptive immunity, cellular composition, and niches and their contribution to AD development and progression.
- Notably, we synthesize the crosstalk between adaptive immunity and the innate immune system of the central nervous system (CNS), which is mainly mediated by glial cells and myeloid cells, and their interrelationships with amyloid-β (Aβ)/Tau pathology.
- We hypothesized that the alterations observed in innate immunity in AD mirror age-related immune alterations, whereas the dysregulation of adaptive immunity contributes more accurately to disease-specific immune responses.
- Targeting adaptive immunity in the context of neuroinflammation may provide new insights into potential therapeutic strategies designed to modulate immune responses, thereby facilitating the diagnosis, intervention, and treatment of AD.
Why it matters
This review discusses evidence that T and B lymphocytes of the adaptive immune system, not just the innate immune system, are involved in the neuroinflammation of Alzheimer's disease. It proposes that targeting adaptive immunity might lead to new treatments, but no such treatment has been tested or proven here.
Study details
- Evidence strengthLow
How this study scored 38/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Chinese Medical Journal) |
| Journal's citation record | 1 / 4 | Chinese Medical Journal: journal h-index 94 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 2 / 7 | Cited 12 times (OpenAlex, 2026-10-10) |
| Citations per year | 2 / 5 | 4.0 citations a year over 3 year(s) since 2025 |
| Impact for its field and year | 3 / 6 | Cited 3.6× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 1 / 6 | Cited by 1 other studies in this library |
| Still being cited | 1 / 4 | Cited 12 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 1 / 4 | Last-listed author Xiaochun Chen: h-index 14 (OpenAlex, whole career) |
| Institution's track record | 0 / 3 | Fujian Medical University: institution h-index 277 (OpenAlex) |
| Multicenter collaboration | 1 / 3 | OpenAlex lists 2 institution(s) in 1 country |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 40764088) |
| Free to read | 2 / 2 | Free to read |
| Total | 38 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.1097/cm9.0000000000003695
- PubMed: 40764088
- Original source →
- Free full text: Chinese Medical Journal →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here. Showing 12 of 30.
Later studies that cite this one
1 study in the alzhub library lists this one in its references.
Related studies in Inflammation and the immune system from nearby years
Also in Inflammation and the immune system
144 studies in the library are filed under Inflammation and the immune system with no topic tag they share with another; these are this study's neighbours in a fixed tour of them. The Inflammation and the immune system hub.